ASH 2024

Visit booth #2455 at the American Society of Hematopathology (ASH) Annual Meeting and Exposition to speak with ARUP hematopathologists and learn about the latest in laboratory testing for hematologic diseases.

December 4, 2024

ARUP Will Showcase Advances in Hematopathology at the 66th ASH Annual Meeting and Exposition

ARUP medical directors will present key hematopathology research at the 66th ASH Annual

Melanie Mallory works at a computer.

Presentations by ARUP medical directors and scientists at AMP 2024 included timely topics in molecular pathology such as automated DNA extraction. Melanie Mallory, MS, pictured above, a lead bioinformatics scientist at ARUP, presented a poster related to the prediction of viral loads for cytomegalovirus.

November 26, 2024

ARUP Research Highlighted at the Association for Molecular Pathology 2024 Annual Meeting…

ARUP medical directors and scientists presented key molecular pathology advancements at

Magnify logo

November 19, 2024

A New Edition of Magnify Is Available and Focuses on the FDA’s Rule To Regulate Lab-Developed Tests…

This edition features interviews with company leaders describing ARUP’s approaches to

Ryan Nelson

Ryan Nelson, PharmD, medical director of Precision Medicine at ARUP, was presented with a Double Helix Award by the American Society of Pharmacovigilance (ASP).

November 15, 2024

ARUP Medical Director Ryan Nelson, PharmD, Receives a STRIPE Double Helix Award

Ryan Nelson, PharmD, received a Double Helix Award for his work on MetaCensus during the Standardizing

Augurex logo and ARUP Laboratories logo

ARUP Laboratories and Augurex Life Sciences Corp. are partnering to incorporate a 14-3-3η test that will aid in the early detection and management of rheumatoid arthritis.

October 21, 2024

Augurex Announces Agreement With ARUP To Expand Access to Advanced Rheumatoid Arthritis Diagnosis

ARUP Laboratories is partnering with Augurex Life Sciences Corp. to include the 14-3-3η test in

A pregnant woman sits on a chair while a clinician is checking her blood pressure.

Preeclampsia is characterized by hypertension and one or more signs of physiologic dysfunction and is difficult to diagnose. A new ARUP Consult® topic aims to help clinicians order the right test at the right time.

September 16, 2024

New Preeclampsia Testing Topic on ARUP Consult Includes Information on Angiogenic Biomarkers

A new ARUP Consult® topic on testing for preeclampsia, which can be difficult to diagnose, distills